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Introduction
The need for highly sensitive and specific
serodiagnostic tests for tuberculosis is well
recognised. The limitations associated with
the bacteriological confirmatory tests, such as
lower sensitivity of the smear and time-
consuming nature of the culture, make it
  imperative that alternativetes t s  be
  developed. Since the first description of
Enzyme Linked Immuno-Sorbent Assay
(ELISA) for tuberculosis by Nassau et l 1, the
assay has been widely tried in serodiagnosis,
using crude extracts as well as purified
fractions. Numerous groups of workers in the
past have used various physico-chemical
methods, such as serial ammonium sulphate
   precipitation, molecular exclusion ion-
exchange, chromatography, acrylamide gel
electrophoresis etc., for purification of
antigen2,5. Recently Nagai et a l6 have
described a serial chromatography procedure
for the isolation of major antigens of
Mycobacterium tuberculosis.
One of the antigens of M. tuberculosis,
which is predominantly present as a secretory
protein in the culture filtrate, namely Antigen
6, has been purified using DEAE Cellulose
chromatography7. A n t i g e n  6 was
characterized and described as a 30 KDa
protein. It has been evaluated for its
diagnostic potential in a study population in
Argentina8 and found to be useful. In the
present study,we have evaluated the
performance of M. tuberculosis Antigen 6 by
ELISA for the serodiagnosis of pulmonary
tuberculosis patients from Madras, south
India.
Material and Methods
Sera
Sera were collected from tuberculosis
patients and normal healthy individuals. The
study groups are described in Table 1. All
s ra were stored at –20°C until use.
In all, 118 sera were included in this
study, of which 62 were obtained from
tuberculosis cases, 29 from normal healthy
volunteers (employees of Tuberculosis
Re earch Centre- TRC), 11 from cases with
non-tuberculous lung disease like asthma,
allergy etc., and 16 from cases with inactive
pulmonary tuberculosis. The sera from
tuberculosiscases could be divided into
(i) bacteriologically confirmed cases (N = 45)
(S+ C+) and (ii) bacteriologically negative, but
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clinically and radiologically diagnosed cases
(N = 17) (S- C-). In the inactive tuberculosis
group, all the 16 subjects were positive by
smear and culture before chemotherapy, but
became quiescent at the end of therapy.
For bacteriological testing, 4 sputum
specimenswere obtained f rom each
individual (2 spot specimens and 2 overnight
collections). Two smears were made from
each of the specimens, stained with auramine-
phenol and counted under the fluorescent
microscope. The smear gradings were done as
described previously9. For culture, each
sputum was treated by Petroff’s method and
inoculated on 2 L-J slopes. The growth was
followed for 8 weeks before classifying the
sputum as negative. The culture grading was
done as previously described10.
Antigens
The antigens used in the assay are Purified
Protein Derivative (PPD) (Central Veterinary
Laboratory, Weighbridge, England) and M.
tuberculosis Antigen 6, which was given as a
kind gift by Prof. Thomas Daniel, Case
Western Reserve University, Cleveland, USA.
It is a 30 KDa protein purified from unheated
culture filtrates of H37Ra by DEAE-Cellulose
chromatography.
Enzyme Linked Immunosorbent Assay
(ELISA)
Polyvinyl microtitre plates (96 wells, U
b ttom, Flow Laboratories, USA) were coated
with 100 µl of PPD or Antigen 6 (5 µg/ml) per
well. For coating, the antigens were diluted in
0.06 M Sodium carbonate-bicarbonate buffer,
pH 9.6 and incubated overnight at 4°C. The
pl tes were washed thrice with PBS
containing 0.1% Tween 20. In order to block
the non specific binding sites, the wells were 
incubated with 1% bovine serum albumin
(BSA) for 1 hour at 37°C. After 3 washings the
plates were incubated with 1 : 100 dilution of
the sera from patients and normals. The
plates were washed after 1 hour of incubation
at 37°C and antihuman IgG-Peroxidase (1/
1000, Sigma) was added as the second
antibody. At the end of 1 hour of incubation
at 37°C and washing, the colour was
developed by the addition of 100 µl of the
substrate (30 mg/50 ml of O-Phenylene
Table 1. Description of study population
Subjects No. of specimens Category
Pulmonary TB patients
positive by smear and culture
45 S+ C+
Pulmonary TB patients
negative by smear and culture
17 S- C-
Healthy laboratory staff
of T.R.C.
29 NHS*
Patients with asthma and
allergy (non-tuberculous
11 NHS*
diseases) from General Hospital, Madras
@ Pulmonary TB patients
one and half years after stopping successful
chemotherapy
16 in active
Total 118
@ All these were positive by smear and culture (S+ C+) before start of chemotherapy and they became
quiescent at the end of chemotherapy
* Non-TB/Healthy Subjects
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diamine and 30 µl of 30% H2O2. After
arresting the reaction with 50 µl of 8N H2SO4,
the optical density (O.D.) was read at 490 nm
in Biotec Microplate, Autoreader EL290
(Biotec Instruments Inc., USA).
While each specimen was set up in
duplicate in each plate, the cut-off point
standard was set up in quadruplicate (from
previous ELISA results, 5 normal sera which
were consistently giving O.D. ranging from
mean to mean + 2 S.D. of the normal sera
were pooled for the reference standards). A
test specimen was classified as positive if its
mean O.D. was greater than or equal to the
mean O.D. of the standard assayed in the
same plate; otherwise, negative.
All the test specimens were coded before
the assays were undertaken. Employing three
plates for each antigen, assays for all the 118
specimens were completed in one day. On the
second day, the assays were repeated under
identical conditions.
Statistical analysis
Statistical analysis was done using
l
StatworksTM Version 1.1 (Cricket Software,
Inc., PA, USA). Student’s t-test was used to
compare the group means. In addition,
Mult iway Anova and nonparametr ic
McNemar test were also employed for
comparison.
Results
The sera belonging to the 4 categories
shown in Table 1 were tested in ELISA with
PPD and Antigen 6. The results are shown in
Fig. 1a and 1b. Each point represents the
mean O.D. obtained with one individual
serum. The group means as well as the cut-off
point values (0.276 for PPD and 0.296 for
Antigen 6) are marked.
In the S+ C+ group, the mean antibody
levels against both PPD and Antigen 6 were
significantly elevated (P < .0001) as compared
to NHS. In the S- C- group also, the group
means were significantly elevated (P < 0.02).
Between the two groups of tuberculosis,
S+ C+ had a higher mean O.D. for both the
antigens, as compared to S- C-. The mean
anti-PPD antibody levels were significantly
Fig. 1a. Antibody level against PPD in four groups as indicated in Fig. Each point represents the mean
O.D. of an individual serum. Group means are indicated by solid horizontal lines; broken
horizontal line indicates the cut-off point.
Fig. 1b. Antibody level against Antigen 6 in four groups as indicated in Fig. Each point represents the
mean O.D. of an individualserum. Group means are indicated by solid horizontal lines; broken
horizontal line indicates the cut-off point.
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Table 2. Percentages of ELISA positive results among tuberculous patients (S+ C+ and S-C-)
Antigen S+ C+ S- C-
No. positive % positive No. positive % positive
PPD 31/45 69 9/17 53
Antigen 6 40/45 89
S+ C+ = Smear positive culture positive tuberculosis
S- C- = Smear negative culture negative tuberculosis
14/17 82
Table 3. Percentages of ELISA negative results among healthy individuals and cured patients
Antigen Healthy staff & asthma and “Cured” TB
allergy patients patients
No. of No. % No. of No. %
sera negative negative sera negative negative
PPD 40 35 88 16 8 50
Antigen6 40 30 75 16 7 44
higher than normals (P < 0.02) in the
“Inactive” group, but the antibodies to
Antigen 6 were not so.
The number and percentage of sera
positive in S+ C+ and S- C- groups, for PPD
and Antigen 6 are indicated in Table 2. The
sensitivities of PPD and Antigen 6 were 69%
and 89% respectively, in the S+C+ group,
while the specificities were 88% and 75%.
Antigen 6 worked better in the S-C- group,
detecting 14 positives out of 17, while PPD
detected only 9 out of 17. The number and
percentage of sera negative in ELISA among
the NHS and “Inactive” are shown in Table 3.
The specificities were 88% and 75% with PPD
and Antigen 6.
Eight and 7 among the sixteen “Inactive”
tuberculosis patients (18 months after
completion of therapy), were positive for PPD
and Antigen 6 respectively. Sera collected
from 5 of these positive individuals, at
various time periods during the treatment (0,
1, 6, /8, 12, 15, 18 and 24 months after start of
treatment), were compared for their antibody
levels. IgG antibodies against Antigen 6 were
detectable at all time periods and found to be
getting lower during the first month of
treatment (the extent varies from patient to
patient) (Fig. 2). Thereafter, the levels either
increased by 6 months or remained steady for
Fig. 2. Antibody level against Antigen 6 in sequential serum samples collected from 5 representative
patients. The points denote the time of collection after the start of treatment : 1, 1, 6/8, 12, 15, 18
and 24 months.
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as long as 24 months. Similar results were
obtained for PPD also (Data not shown).
Table  4  shows the d iagnost ic  test
characteristics achieved by ELISA. Positive
predictive values (S+C+ Group) for Antigen 6
and PPD were 0.80 and 0.86 respectively,
while negative predictive values were 0.86
and 0.71. The positive predictive values were
almost similar for both the antigens in both
the groups (S+C+ and S-C-). However,
Antigen 6 has a higher negative predictive
value (0.86 as against 0.71). In the S-C- group
also, the negative predictive value for
Antigen 6 was higher than that of PPD (0.91
as against 0.81).
Discussion
Antigen 6 used in this study is a well
characterized antigen11. It is a purified,
homogeneous30  KDa  p ro te in  o f  M.
tuberculosis. Antigen 6 is one of the major
secreted antigens of M. tuberculosis. It is a
widely crossreacting antigen between
different mycobacterial species. For example,
Antigen 6 is identical to one of the antigens in
BCG 86 complex, comprising 3 proteins of
molecular weight 29-31KDa12. Isolation of this
a n t i g e n  i s a c h i e v e d  b y simple
physicochemical procedures l ike ion
exchange chromatography7.
The sensitivity of detection in the S+C+
group was 69% for PPD and 89% for Antigen
6, while specificity was 88% and 75%
respectively. PPD classified 5/40 NHS as
positive, Antigen 6 classified 10/40 as
positive. NHS group consisted of 2 sub-
groups : TRC volunteers and those with non
mycobacterial lung diseases. Out of the 11
non-mycobacterial lung disease patients, only
one was identified as positive by Antigen 6.
The additional 9 false positives happened to
lie in the group of TRC volunteers. In the SC-
gr up, 14/17 patients were identified as
positive by Antigen 6, while only 9/17 were
recognised as positive by PPD. Thus, Antigen
6 was more sensitive and more efficient in
detecting disease at an earlier stage than PPD.
This observation corroborates well with the in
vitro observation13 that large quantities of this
antigen could be found in the culture
supernatants as early as day 3. Since it is an
early antigen, there is a likely hood of Antigen
6 being produced in large quantities at earlier
stages of the disease process and stimulating
antibody production before other
bacteriological parameters become
measurably high.
In the “Inactive’ group, 8/16 and 7/16 sera
remained positive for PPD and Antigen 6,
re pectively. For 5 of these patients, the test
was repeated with sera collected at various
time periods during therapy (0, 1, 6/8, 12, 15,
18, and 24 months after start of treatment).
Antibodies to PPD and Antigen 6 were
positive at all time periods. There was an
initial lowering at 1 month (the extent varied
from patient to patient) and the level
increased by the 6th month or remained
constant upto 24 months. During treatment,
Table 4. Diagnostic test characteristics (95% confidence limits) achieved using ELISA with
PPD and Antigen 6
Antigen Category Sensitivity Specificity Predictive Values
Positive Negative
PPD S+C+ .69(.53-.82) – .86(.70-.95) .71 (.57-.83)
S-C- .53(.28-.77) – .64(.35-.87) .81 (.66-.92)
– .88(.73-.96) –
Antigen6 S+C+ .89(.76-.96) – .80(.66-.90) .86(.73-.97)
S-C- .82(.56-.96) – .58(.37-.78) .91 (.75-.98)
NHS .75(.59-87) –
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the antibodies did not correlate with the
bacteriological status of the patients, since all
these patients converted to sputum negativity
within 1 month of treatment. Therefore,
antibodies for Antigen 6 are not of much
prognostic significance.
Persistence of antibodies long after the
completion of therapy has been reported for
other purified M. tuberculosis antigens like
Antigen 514. They persist for more than 24
months and in many patients upto several
years. In a recent ELISA study with Antigen
6, Sada et al8 have observed that 1 out of 6
inactive pulmonary tuberculosis patients had
high antibody titres for Antigen 6.
The sparsenessof specific antibody
response before treatment is quite striking
despite the general hyperglobulinaemia
present in tuberculosis. One explanation
offered is that the mycobacterial lipid coat
insulates the cell wall glycoproteins and
thereby prevents stimulation of humoral
immunity. Antibiotic therapy results in the
death of mycobacterial cells and release of
antigen., which elicit a higher antibody
response15. There is also a strong evidence for
the action of suppressor cells in tuberculosis.
The antibody response as measured by
plaque forming cel l  assay (PFC) was
drastically reduced in tuberculosis patients
and found to increase after treatment16. Using
the soluble antigen-fluorescent antibody test,
Toussaint et al17 have shown that pre-existing
antibody levels increased reaching maximal
levels within 60-90 days. Janicki and co-
workers18 have observed increased
concentration of antibodies post-treatment, in
the one dimensional immunoelectrophoresis
technique. This effect was maximal after the
third month of treatment. Similar findings
were reported by Cole et al19 also, by
employing latex agglutination test. While all
the above mentioned studies have used crude
extracts, our study was carried out with a
s ing le ,  pu r i f i ed  Ant igen  6  and  the
enhancement of antibody synthesis after the
treatment could still be observed.
In the present study, the specificity of
Antigen 6 is not very high, even though the
sensitivity is 89%. Therefore, ELISA using
Antigen 6 by itself can not work as a good
diagnostic test. To evaluate its potential as a
screening agent, it has been planned to collect
a large number of finger prick blood
sp cimens and subject them to ELISA test.
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